Lungs News and Research

RSS

Researchers develop new type of E. coli that kills bacteria responsible for hard-to-treat infections

The notorious bacteria E. coli is best known for making people sick, but scientists have reprogrammed the microbe - which also comes in harmless varieties - to make it seek out and fight other disease-causing pathogens.

3 Oct 2013

'Early-term' babies more likely to experience higher risk for adverse health outcomes

Babies considered "early-term," born at 37 or 38 weeks after a mother's last menstrual period, may look as healthy as full-term babies born at 39-41 weeks, but a new study published by University at Buffalo physicians in JAMA Pediatrics has found that many of them are not.

3 Oct 2013

Queen's research to investigate how superbug affects cystic fibrosis patients

Queen's University Belfast is to lead a £139,000 study into the way cystic fibrosis sufferers are affected by a superbug that destroys lung function.

2 Oct 2013

Researchers develop new approach to combat tubercle bacillus

A new approach to combating the tubercle bacillus, the microorganism that kills some 1.5 million people in the world each year, has been developed by a French-British team including scientists from CNRS, Inserm, the Institut Curie and Université Toulouse III - Paul Sabatier.

2 Oct 2013

Exposure to farming environment may reduce symptoms of hypersensitivities, allergies

Adults who move to farming areas where they experience a wider range of environmental exposures than in cities may reduce the symptoms of their hypersensitivities and allergies considerably. This is the result of new research from Aarhus University.

1 Oct 2013

Report: More Hispanic Texans die from cancer than any other cause

More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.

1 Oct 2013

Liquid biopsy: New device could help doctors diagnose and treat cancers

A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood-and it can support the cells' growth for further analysis.

1 Oct 2013

MD Anderson-developed aerosol triggers innate immunity to squelch infections

Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.

1 Oct 2013

Mexican scientists reveal aflatoxins relationship with cervical and liver cancer in humans

Mexican scientists identified and quantified the amount of aflatoxins (carcinogenic) in food such as corn tortilla, rice, chili pepper, processed sauces, chicken breast and eggs, and revealed its relationship with cervical and liver cancer in humans.

1 Oct 2013

NIH award strengthens pioneering work in cystic fibrosis at Dartmouth's School of Medicine

The National Institutes of Health (NIH) has awarded a $5.9 million grant to support an Institutional Development Award (IDeA) Lung Biology Center of Biomedical Research Excellence (COBRE) at the Geisel School of Medicine at Dartmouth.

1 Oct 2013

Vitamin D levels linked to emphysema

Researchers have found a relationship between emphysema and serum vitamin D levels, suggesting that the vitamin may play a role in modulating lung structure.

30 Sep 2013

Intercalated erlotinib/chemotherapy shows mixed results in NSCLC

A study comparing erlotinib alone with erlotinib intercalated with chemotherapy has failed to demonstrate a clear advantage of the combination strategy when used to treat relapsed patients with non-small-cell lung cancer, Dutch researchers report.

30 Sep 2013

Use of SHOX2 DNA measurement improves cancer staging tools

Findings indicate that assessment of SHOX2 DNA methylation level in lymph node tissue improves the negative predictive value of endobronchial ultrasound with transbronchial needle aspiration, as well as endoscopic lung cancer staging in general.

30 Sep 2013

Scientists discover two new compounds that could help treat CF patients having common mutation

Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation.

30 Sep 2013

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers.

30 Sep 2013

Chinese and Western medicine combination could offer new hope for cancer treatments, therapies

Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones.

30 Sep 2013

Pan-Cancer Initiative: Patterns Emerge Across Diverse Tumor Types

...

27 Sep 2013

State highlights: Jails treat huge number of mentally ill; class action bid denied in Fla. lawsuit over disabled children in nursing homes

America's lockups are its new asylums. After scores of state mental institutions were closed beginning in the 1970s, few alternatives materialized. … The country's three biggest jail systems -- Cook County, in Illinois; Los Angeles County; and New York City -- are on the front lines. With more than 11,000 prisoners under treatment on any given day, they represent by far the largest mental-health treatment facilities in the country. By comparison, the three largest state-run mental hospitals have a combined 4,000 beds.

27 Sep 2013

Cleaning product-related asthma goes beyond irritation

Research from Belgium indicates that a substantial proportion of those who have occupational asthma related to cleaning agents have specific airway sensitivity to the components of detergents.

27 Sep 2013

Time to first cigarette independently predicts lung cancer

The time to first cigarette after waking is an independent risk factor for lung cancer, a Japanese case-control study has found.

27 Sep 2013

Lungs News and Research

Researchers develop new type of E. coli that kills bacteria responsible for hard-to-treat infections

'Early-term' babies more likely to experience higher risk for adverse health outcomes

Queen's research to investigate how superbug affects cystic fibrosis patients

Researchers develop new approach to combat tubercle bacillus

Exposure to farming environment may reduce symptoms of hypersensitivities, allergies

Report: More Hispanic Texans die from cancer than any other cause

Liquid biopsy: New device could help doctors diagnose and treat cancers

MD Anderson-developed aerosol triggers innate immunity to squelch infections

Mexican scientists reveal aflatoxins relationship with cervical and liver cancer in humans

NIH award strengthens pioneering work in cystic fibrosis at Dartmouth's School of Medicine

Vitamin D levels linked to emphysema

Intercalated erlotinib/chemotherapy shows mixed results in NSCLC

Use of SHOX2 DNA measurement improves cancer staging tools

Scientists discover two new compounds that could help treat CF patients having common mutation

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

Chinese and Western medicine combination could offer new hope for cancer treatments, therapies

Pan-Cancer Initiative: Patterns Emerge Across Diverse Tumor Types

State highlights: Jails treat huge number of mentally ill; class action bid denied in Fla. lawsuit over disabled children in nursing homes

Cleaning product-related asthma goes beyond irritation

Time to first cigarette independently predicts lung cancer

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News